TP53 and neoplasm: Finally, unique CTC-specific mutations (FOXA1 V229I, PIK3CA N114D, PTEN S227F and TP53 S215G) suggest ongoing real-time clonal evolution of the disease, further supporting the utility of parallel cfDNA and CTC analyses in capturing tumour heterogeneity.